SCHEMBL4587733

SCHEMBL4587733

CNC(=O)C(O)Cc1ccc(C(=O)OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.53
CYP4A11 Q02928 2/20 0.49
CA1 P00915 6/20 0.48
CA2 P00918 6/20 0.48
CYP4F2 P78329 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
CA7 P43166 1/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
ERAP2 Q6P179 1/20 0.45
LNPEP Q9UIQ6 1/20 0.45
MAPK1 P28482 1/20 0.44
AR P10275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4588604 0.83 LOXL2 (0.56) LOXL2CYP4A11CA1CA2CYP4F2
SCHEMBL4589135 0.83 LOXL2 (0.56) LOXL2CYP4A11CA1CA2CYP4F2
SCHEMBL4587583 0.83 ALDH1A1 (0.48) MEN1KMT2AMAPTTDP1
SCHEMBL5177723 0.80 LOXL2 (0.59) LOXL2CYP4A11CA1CA2CYP4F2
SCHEMBL10777253 0.78 LOXL2 (0.58) LOXL2CYP4A11CA1CA2CYP4F2
SCHEMBL24988006 0.78 NPC1 (0.50) MEN1KMT2AMAPK1
SCHEMBL3156555 0.78 NPC1 (0.50) MEN1KMT2AMAPK1
SCHEMBL15772079 0.78 LOXL2 (0.61) LOXL2CYP4A11CA1CA2CYP4F2
SCHEMBL25440208 0.78 NPC1 (0.50) MEN1KMT2AMAPK1
SCHEMBL765010 0.78 LOXL2 (0.61) LOXL2CYP4A11CA1CA2CYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973405-A2 HYDROXYALKYLARYLAMIDE DERIVATIVES Merck & Co., Inc. (US) 2008-10-01 EP disclosed
WO-2007087130-A2 HYDROXYALKYLARYLAMIDE DERIVATIVES MERCK & CO., INC. (US) 2007-08-02 WO disclosed